TH26552A - Remedy - Google Patents
RemedyInfo
- Publication number
- TH26552A TH26552A TH9601001364A TH9601001364A TH26552A TH 26552 A TH26552 A TH 26552A TH 9601001364 A TH9601001364 A TH 9601001364A TH 9601001364 A TH9601001364 A TH 9601001364A TH 26552 A TH26552 A TH 26552A
- Authority
- TH
- Thailand
- Prior art keywords
- amoxicillin
- day
- clavulanic acid
- bacterial infections
- trihydrate
- Prior art date
Links
- 229940079593 drug Drugs 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 208000035143 Bacterial infection Diseases 0.000 claims abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract 2
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 claims abstract 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims 3
- 229960003022 amoxicillin Drugs 0.000 claims 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims 2
- QJVHTELASVOWBE-AGNWQMPPSA-N (2s,5r,6r)-6-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 QJVHTELASVOWBE-AGNWQMPPSA-N 0.000 claims 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 claims 1
- 229960004920 amoxicillin trihydrate Drugs 0.000 claims 1
- 229960003324 clavulanic acid Drugs 0.000 claims 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- -1 amoxy Chemical group 0.000 abstract 1
- 239000006194 liquid suspension Substances 0.000 abstract 1
- 150000004684 trihydrates Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Abstract
การประดิษฐ์นี้ทำให้มีสารแขวนลอยผสมตามสูตรที่เป็นของเหลวในตัวกลางที่ เป็นน้ำสำหรับใช้กับเด็ก ซึ่งประกอบด้วยอามอกซี ซิลลินไตรไฮเดรทและโปแตสเชียมคลาวู- ลาเนทในอัตราสาวนตั้งแต่ 61 ถึง 8:1 เพื่อใช้ในการกำหนดการให้ยาตามขนาดแบบ BID เพื่อรักษาการติดเชื้อแบคทีเรีย: สิทธิบัตรยา This invention provides a formulated liquid suspension in a medium that It is water for use with children. Which contains amoxy Cylin trihydrate and potassium clavulanate at a rate of 61 to 8: 1 for use in BID dosing to treat bacterial infections: drug patent.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH26552A true TH26552A (en) | 1997-09-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0009719B8 (en) | treatment process | |
| HUP9901437A2 (en) | Pharmaceutical formulation, containing amoxycillin and clavulanate | |
| EP1243267A3 (en) | Amoxycillin and clavulanate containing pharmaceutical formulation | |
| HUP0203556A2 (en) | Pharmaceutical compositions containing oxcarbazepine and their use | |
| RO116343B1 (en) | Pharmaceutical composition and method for treating bacterial infections in pediatric patients | |
| BR9810592A (en) | Compound, processes for preparing a compound, for treating or preventing diseases of the endocrine system and for the manufacture of a drug, pharmaceutical composition, and, use of a compound | |
| ES543826A0 (en) | A PROCEDURE FOR PRODUCING A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT IN THE FORM OF A UNITARY DOSAGE OF PROLONGED RELEASE | |
| BR9711642A (en) | Use of a combination of amoxicillin and clavulanate in the manufacture of a drug for the treatment of drug-resistant streptococcus pneumonia | |
| CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
| ATE334655T1 (en) | PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE | |
| GB1515241A (en) | Beta-lactam antibiotics | |
| CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
| TH26552A (en) | Remedy | |
| Long | Thiazole derivatives of sulfanilamide: sulfathiazole and sulfamethylthiazole | |
| ES2145065T3 (en) | GRANULAR PREPARATION. | |
| Disney et al. | The use of cefaclor in the treatment of beta-haemolytic streptococcal throat infections in children | |
| RU2004112422A (en) | ROUVASTATIN IN PREDEDENTIONAL CONDITIONS | |
| Petroni et al. | Alcohol content of liquid medicinals | |
| RU2007116477A (en) | METHOD FOR TREATMENT OF BACTERIAL PURULENT MENITITIS IN CHILDREN | |
| WO1988007367A3 (en) | Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs | |
| AP9901724A0 (en) | Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients. | |
| KR960003718A (en) | Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases | |
| GB2323532B (en) | Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients | |
| MARKOWITZ | Long-acting penicillins: historical perspectives | |
| JPS6189A (en) | Novel 6 beta-halopenicillanate, manufacture and use |